InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
ernie44 Free
11/04/16 2:31 PM
profile icon
ernie44 Free
08/15/16 4:49 PM
profile icon
ernie44 Free
07/06/16 6:06 PM
profile icon
ernie44 Free
07/02/16 5:19 PM
profile icon
ernie44 Free
06/23/16 12:21 PM
profile icon
ernie44 Free
05/23/16 1:52 PM
profile icon
ernie44 Free
05/16/16 2:13 PM
profile icon
DK_trader Free
05/11/10 1:51 PM
profile icon
OAKTRADES Free
04/29/10 3:10 PM
profile icon
10Q Detective Free
01/25/10 1:45 PM
profile icon
lordwinmore Free
01/09/08 1:01 PM
profile icon
frenchee Free
01/08/08 11:11 PM
profile icon
lordwinmore Free
11/02/07 4:03 PM
profile icon
lordwinmore Free
11/02/07 4:03 PM
profile icon
rkbeemer Free
09/16/07 8:15 AM
profile icon
frenchee Free
09/15/07 3:45 PM
profile icon
frenchee Free
09/13/07 8:40 PM
profile icon
rkbeemer Free
09/13/07 8:38 PM
profile icon
frenchee Free
09/13/07 4:10 PM

King Pharmaceuticals (KG) RSS Feed

Followers
2
Posters
7
Posts (Today)
0
Posts (Total)
19
Created
09/13/07
Type
Free
Moderators
This board is for fundamental and technical discussion about King Pharmaceuticals, Inc., KG. KG is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products. The Company operates through five segments: Branded pharmaceuticals, Meridian Medical Technologies, Royalties, Contract manufacturing and other. On February 26, 2007, the Company acquired all the rights to Avinza in the United States, its territories and Canada from Ligand Pharmaceuticals Incorporated. In February 2007, King announced that the United States Food and Drug Administration approval of its manufacturing and production facility in Rochester, Michigan, for its Bicillin product line. On January 9, 2007, king obtained a license to the hemostatic products designed for use outside of catheterization and electrophysiology laboratories by Vascular Solutions, Inc. On March 1, 2006, it acquired substantially all of the assets of Allerex Laboratory LTD. Weekly Five-Year Charts Daily Nine-Month Charts
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
KG Latest News
  • No Recent News Available for this company!
New Post